| 41/94 | US=49-G / Câncer Cuevas H, Boudreau N. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2009. p. 25-42. ISBN 978-0-12-3747730. GERENCIANDO ANGIOGENESE TUMORAL; LICOES DE VEGF-RESISTENTES TUMORES E FERIDAS; ANGIOGENESE; VEGF E ANGIOGENESE TUMORAL; VEGF E RECRUTAMENTO DE EPC NA ANGIOGENESE TUMORAL; LIMITACOES NO ALVO VEGF |
| 42/94 | US=28 / Biol/Mol Dewhirst MW, Cao Y, Vlabovic G. The cycle between angiogenesis, perfusion, hypoxia in tumors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 27-47. ISBN 978-1-58829-870-6. |
| 43/94 | US=28 / Biol/Mol Aiyer AR, Varner JA. The role of integrins in tumor angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 49-71. ISBN 978-1-58829-870-6. INTEGRINAS NA ANGIOGENESE TUMORAL; INTEGRINA; GENESE; APOPTOSE; CELULAS ENDOTELIAIS; PERICYTE |
| 44/94 | US=28 / Biol/Mol Lu C, Sood AK. Role of pericytes in angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 117-32. ISBN 978-1-58829-870-6. ROLE OF PERICYTES IN ANGIOGENESIS; PERICYTE; ENDOTHELIAL CELL; ANGIOGENESIS; PDGF-B; PDGFR-B |
| 45/94 | US=28 / Biol/Mol Keane MP, Belperio JA, Strieter RM. Chemokines in angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 155-70. ISBN 978-1-58829-870-6. QUIMIOCINAS NA ANGIOGENESE; RECEPTOR QUIMIOCINAS; ANGIOGENESE; CANCER |
| 46/94 | US=28 / Biol/Mol Kabayashi H, DeBush LM, Lin PC. Angiopoietin/Tie2 signaling regulates tumor angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 171-87. ISBN 978-1-58829-870-6. ANGIOPOIETINA; AMARRAR; ANGIOGENESE TUMORAL; VEGF; CANCER; METASTASE |
| 47/94 | US=28 / Biol/Mol Kalva SP, Namasivayam S, Kabayashi H, DeBush LM, Lin PC. Imaging angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 189-203. ISBN 978-1-58829-870-6. IMAGEM ANGIOGENESE; PERFUSAO CT; PERFUSAO MRI; COM CONTRASTE DE ULTRA-SOM; ANGIOGENESE |
| 48/94 | US=23 / Câncer Bach-Gansmo T, Tobin D. Breast cancer: detection by in-vivo imaging of angiogenesis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 33-42. ISBN 978-1-4020-8368-6. CANCER DE MAMA; ANGIOGENESE IN VIVO; INTEGRINAS; CINTILOGRAFIA; TC-NC100692; EXPERIENCIA CLINICA INICIAL; RAIOS GAMA; CAMARA GAMA |
| 49/94 | US=28 / Biol/Mol Han L, Lorincz AM, Sukumar S. Regulation of angiogenesis in cancer and its therapeutic implications. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 331-49. ISBN 978-1-58829-870-6. |
| 50/94 | US=28 / Biol/Mol DuBois S, Demetri G. Angiogenesis and angiogenesis inhibition in sarcomas. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 353-69. ISBN 978-1-58829-870-6. |
| 51/94 | US=28 / Biol/Mol Nilsson MB, Hanraban EO, Heymach JV. Angiogenesis inhibitors for the treatment of lung cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 409-26. ISBN 978-1-58829-870-6. |
| 52/94 | US=28 / Biol/Mol Ribatti D, Ponzoni M. Angiogenesis in malignant and non-malignant pediatric tumors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 475-86. ISBN 978-1-58829-870-6. |
| 53/94 | US=28 / Biol/Mol Longo R, Torino F, Gasparini G. Prognostic and predictive significance of surrogate biomarkers of angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 487-508. ISBN 978-1-58829-870-6. |
| 54/94 | US=35 / Biol/Mol Keith B, Simon MC. Tumor angiogenesis. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 241-51. ISBN 978-1-4160-3703-3. |
| 55/94 | US=2 / Tórax Hanrahan EO, Nilsson M, Heymach JV. Tumor angiogenesis: biology and therapeutic implications for lung cancer. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 369-85. ISBN 978-1-4051-5112-2. ANGIOGENESE TUMORAL; TERAPEUTICA PARA O CANCER DE PULMAO; ANGIOGENESE NO CANCER DE PULMAO |
| 56/94 | US=39 / Câncer Francia G, Emmenegger U, Kerbel RS. Angiogenesis inhibitors as enabling agents for the chemotherapeutic treatment of metastatic disease. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 63-80. ISBN 978-1-58829-989-5. INIBIDORES DA ANGIOGENESE; TRATAMENTO QUIMIOTERAPEUTICO; DOENCA METASTATICA |
| 57/94 | US=65 / Biol/Mol Berndt S, Bruyère F, Jost M, Noël A. In vitro and in vivo models of angiogenesis to dissect MMP functions. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 305-25. ISBN 978-0-387-69056-8. ANGIOGENESE; IN VIVO; IN VITRO; ANGIOGENESE. TIPOS; ENSAIO DE INVASAO DE CELULAS; ENSAIO DE FORMACAO DE TUBO; ENSAIO DO ANEL AORTICO; ENSAIO DE CAMARA; ENSAIO DE TAMPAO DE MATRIGEL; ZEBRAFISH; LINFANGIOGENESE |
| 58/94 | US=84 / Biol/Mol Berberian G, Malhotra D, Langenfeld JE. TGF-B superfamily members in normal and tumor biology: bone morphogenic proteins and angiogenesis in developing tumors. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 373-81. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ACTIVINA; PROTEINAS MORFOGENETICAS DO OSSO; INIBINAS; ALK2; ALK3; ALK6; ACTIVINA RECEPTOR TIPO II; BMP RECEPTOR TIPO II |
| 59/94 | US=84-A / Biol/Mol Yee KO, Lawler J. Transformig growth factor-B in developing and advanced cancers: regulation of angiogenesis an tumor growth by thrombospondin-1. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 401-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FATOR TRANSFORMADOR DE CRESCIMENTO - B; TROMBOSPONDINA-1; ANGIOGENESE; CANCER; PLASMINOGENIO; GLIOMA; CANCER DE MAMA; MODELO DO RATO; CELULAS ENDOTELIAIS |
| 60/94 | US=90 / Biol/Mol Box C, Peak J, Rogers S, Eccles S. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: EGFR signaling in invasion, angiogenesis and metastasis. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 257-76. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. INVASAO; ADESAO; MOTILIDADE; PROTEOLISE; ANGIOGENESE; LINFANGIOGENESE; METASTASE |